Skip to main content
. 2007 Aug 24;57(3):411–423. doi: 10.1007/s00262-007-0383-3

Fig. 6.

Fig. 6

In vivo anti-tumor activity of NK-92-scFv(Leu-16)-ζ cells. About 4 × 106 Raji cells were mixed with PBS, or NK-92-scFv(Leu-16)-ζ or parental NK-92 cells at an effector to target ratio of 5:1 as indicated and immediately injected subcutaneously into the flanks of NOD/SCID γ−/−c mice. Tumor growth was followed by caliper measurements. Mice were sacrificed when tumors reached 1.5 cm in diameter or when animals appeared to be in distress